Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 08 February, 2019

Competition and Mkts

Merger Update

RNS Number : 4365P
Competition and Markets Authority
08 February 2019
 

CMA to launch in-depth investigation of Tobii / Smartbox merger

The CMA has today referred Tobii's purchase of Smartbox for an in-depth investigation, after finding competition concerns.

Tobii and Smartbox design and supply technology to enable people with complex speech and language needs to communicate. These solutions include specialised hardware and software, such as speech generating devices.

As part of its initial, Phase 1, investigation the Competition and Markets Authority (CMA) found the deal could lead to less choice, higher prices and reduced innovation for customers.

The companies are the leading suppliers in this sector, and each other's main competitors. As such, the CMA is concerned that the merged company would face little competition, which could lead to a reduced range of products being offered, higher prices and fewer new products being developed.

In January, the CMA said that it would refer the merger for a full investigation unless the parties offered acceptable undertakings to address the CMA's competition concerns. Tobii offered undertakings intended to address the CMA's concerns. After careful consideration, the CMA was not confident that these would resolve the concerns in a clear-cut manner. The CMA has therefore decided to refer the merger for an in-depth Phase 2 investigation.  

A decision on the merger will be made by a group of independent panel members supported by a case team of CMA staff. More information can be found on the Tobii / Smartbox case page.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MERSSWESWFUSELE

a d v e r t i s e m e n t